Stada Arzneimittel AG is a Germany-based holding company active in the pharmaceutical sector and healthcare market. The Company develops and markets products with off-patent active pharmaceutical ingredients. The Company’s primary business segments are Generics and Branded Products. The Generics segment comprises low-priced and active-ingredient products. The Branded Products segment focuses on multisource products accessible without active ingredient research, notably anti-enzymatic food intolerance drugs that are marketed by the subsidiary SCIOTEC Diagnostics Technologies. The Company's generic drugs are marketed by the Group subsidiary, STADApharm GmbH. Non-core activities of the Company encompass Commercial Business segment, which includes activities with primarily trading character such as wholesaling activities. The Company operates STADA Pharmaceuticals Australia Pty Ltd and STADA IT SOLUTIONS DOO as subsidiaries.

Pharmaceutical

Stada Group

Peter Goldschmidt

Patrick Genestin

Christos Gallis

Stéphane Jacqmin

Boris Doebler

Simone Berger

Christoph Dengler

Bryan Kim

Miguel Pagan Fernandez

Stephan Eder

Volker Sydow

Frank Staud

Yann Brun

The Directors Team at Stada Group is composed of high-level executives overseeing various strategic and operational functions within the company. This team is responsible for guiding corporate governance, quality management in Western Europe, global product development, legal affairs, sustainability, supply chain planning, commercial projects, data analytics, and business excellence. Their collaborative efforts ensure the company remains a leader in the pharmaceutical sector by optimizing operations, compliance, project management, and strategic initiatives across all business segments.

Directors Team

Marketing

Global Operations

Directors Team

About

Team members

Other teams at Stada Group

Marketing

Global Operations